ClinicalTrials.Veeva

Menu

HeartLight X3 Endoscopic Ablation System With Excalibur Balloon for Treatment of Symptomatic Persistent AF

C

CardioFocus

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: HeartLight X3

Study type

Interventional

Funder types

Industry

Identifiers

NCT03988244
25-4911

Details and patient eligibility

About

The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the original HeartLight catheter in the treatment of persistent atrial fibrillation.

Enrollment

11 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • early persistent AF, failure of at least one AAD, others

Exclusion criteria

  • overall good health as established by multiple criteria

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

11 participants in 1 patient group

HeartLight X3
Experimental group
Description:
Pulmonary vein isolation using HeartLight X3
Treatment:
Device: HeartLight X3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems